| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019426 |
| Receipt No. | R000022467 |
| Official scientific title of the study | A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin |
| Date of disclosure of the study information | 2015/10/30 |
| Last modified on | 2016/10/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin | |
| Title of the study (Brief title) | A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Topical application of both test product and control product for 4weeks and 8weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)Healthy males
2)Individuals who drink only a few cup of coffee per day |
|||
| Key exclusion criteria | 1)Individuals who have some skin diseases (atopic dermatitis and so on)
2)Individuals who have some skin troubles in applied positions 3)Individuals who already got dark skin with excessive sunburn 4)Individuals who play outdoor actions with excessive sunburn routinely 5)Individuals who apply cosmetics or drugs for beauty to target skins, and take drugs for improvement of fleck, age spot and suntan 6)Individuals who have some diseases (endocrine, liver, kidney, heart and blood pressure and so on), or have had some diseases until a month 7)Individuals who have some diseases (hypertension, cardiac disease, diabetes, Raynaud disease, rosacea, telangiectasia) or feel excessive sensitivity to cold 8)Individuals who have an abnormal cardiac rhythm 9)Individuals who usually take some medications 10)Individuals who got some cosmetic surgery/implant 11)Individuals who have or might have same dermatological diseases (pollen, rhinitis, and allergic dermatitis) 12)Individuals who have or might have same allergy of medicine 13)Smoker 14)Individuals who drink much coffee per day 15)Individuals who are judged inappropriate for the study by study director and/or study doctor |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Takatoshi Murase |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | 0285-68-7871 |
| murase.takatoshi@kao.co.jp | |
| Public contact | |
| Name of contact person | Katsuyuki Yuki |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | 0285-68-7460 |
| Homepage URL | |
| yuki.katsuyuki@kao.co.jp | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022467 |